GLP-1RGIPR co-agonists such as tirzepatide have shown strong efficacy in reducing body weight, improving glycaemic control, and even benefiting liver outcomes in metabolic dysfunction-associated steatohepatitis (MASH)
It is a nice addition to the service menu, but not necessarily a must-have for most weight loss patients
The dynamic landscape, characterized by established agents and novel contenders, necessitates ongoing research to optimize therapeutic strategies, ensuring efficacy while mitigating potential risks
This tripeptide binds copper ions to deliver potent anti-inflammatory effects, promote tissue remodeling, and enhance skin quality
In every case where the committee voted yes, it did so against the written recommendation of FDA career staff, who had concluded after months of review that none of the seven substances met the agency's four-part evidentiary standard for inclusion on the 503A Bulk Drug Substances List